Clinical trial for COPD
Official title Cervical Nags Effect on Accessory Muscles
ClinicalTrials.gov ID: NCT06736145
What this study is testing
- What it's testing
- The aim of this work is to record changes on accessory muscles especially sternocleidomastoid and scalene after applying cervical NAGs in COPD patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50
You may be able to join if
- Registered with history of moderate (II) to severe (III) grade COPD (for a minimum of 1 year) will be included in the study.
- Patients who are clinically stable.
You likely can't join if
- Patients who have any pre-existing cervical spine disease.
- Patients who have any cardiac disease.
- Other respiratory co-morbidities
- Patients who have severe dizziness or coughing
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Federal, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Federal, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.